Stay updated on Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.

Latest updates to the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Publications section now clarifies that entries are auto-filled from PubMed and shows updated revision labels (v3.3.2; v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedRemoved the government funding lapse notice that was displayed on the page; there are no changes to study content or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedNo user-facing changes detected between the old and new screenshots; the page content and layout appear unchanged.SummaryDifference0.2%

- Check70 days agoChange DetectedUpdated the page to v3.2.0 and added a government operating-status notice; removed the previous v3.1.0 tag.SummaryDifference3%

- Check77 days agoChange DetectedPage now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.SummaryDifference0.4%

- Check92 days agoChange DetectedUpdated release version from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in HCC After Sorafenib Clinical Trial page.